Dr Katharine Giles

OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™.

Perth-based OncoRes Medical has secured $27 million from Brandon Capital's BB6 Fund, Morgans, Radar Ventures and others to advance its Elora breast-surgery imaging device through an Australian clinical trial toward FDA approval.

Also oncoresmedical.com

Through a different lens: How Kath Giles and OncoRes Are Reinventing Breast Cancer Surgery

Profile of OncoRes Medical CEO Katharine Giles, tracing her path from surgeon to venture investor and her leadership of the Western Australian medtech firm developing a handheld device for precise breast cancer surgery.

National Reconstruction Fund picks up half the tab in IoT nanosatellite maker Myriota’s $50 million raise

Adelaide IoT satellite firm Myriota has raised $50 million, led by the National Reconstruction Fund’s $25 million contribution, with Main Sequence and Inter Valley Ventures also backing; an NRFC director has resigned.

Also Business News Australia

State Government Backs OncoRes Medical with Funding to Manufacture Digital Cancer ImagingDevice in WA

OncoRes Medical has received a $3 million WA government grant to manufacture its surgical cancer-imaging device locally, its latest funding after a 2022 Series A2 and earlier state and federal grants.

Also Brandon BioCatalyst portfolio·Startup News (WA)

Australian medical device company secures additional $12.5m to advance its breast cancer imaging system towards clinical trials

Perth medtech OncoRes Medical announced $12.5 million: a $9.5 million Series A2 co-led by Brandon Capital and Australian Unity, plus a $3 million government grant, and hired a new R&D vice president.

Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Startup News (WA)